Search for: "US INVENTOR, INC." Results 1101 - 1120 of 1,898
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2011, 11:53 am by Stephen Jenei
., Inc, Supreme Court No. 10-1150, to consider whether to set limits on when inventors can patent medical diagnostic tests. [read post]
14 Nov 2011, 10:15 am by Joe Palazzolo
– it could reshuffle the deck in favor of the proverbial inventor-in-a-garage. [read post]
9 Nov 2011, 12:01 pm by Dennis Crouch
Judge Kimberly Moore highlighted this issue in her recent dissent from the court's denial of en banc rehearing of Retractable Technologies, Inc. v. [read post]
5 Nov 2011, 7:28 am by Lawrence B. Ebert
See In re Smith, 714 F.2d 1127, 1135 (Fed.Cir.1983) ("The experimental use exception . . . does not include market testing where the inventor is attempting to gauge consumer demand for his claimed invention. [read post]
4 Nov 2011, 9:58 am
The European Patent Office grants patents to inventors in 38 member countries. [read post]
4 Nov 2011, 8:56 am by Rantanen
By Jason Rantanen Retractable Technologies, Inc. v. [read post]
1 Nov 2011, 1:13 am by John Day
One World Technologies, Inc., No. 10-1824 (1st Cir. 10/5/11),    Osorio argued that the BTS 15 was unacceptably dangerous due to a defective design. [read post]
31 Oct 2011, 10:22 am
As characterized by Mayo in its brief to the Supreme Court, the inventors did not "invent" these correlations; rather, they simply observed the correlations in a patient population. [read post]
31 Oct 2011, 7:30 am
Teleflex Inc., the Supreme Court overruled the Federal Circuit's nonobviousness analysis using the TSM test, finding that an explicit teaching, suggestion, or motivation to combine prior art references in the prior art was not required to obviate the obviousness of patents based on the combination of multiple prior art references. [read post]
26 Oct 2011, 7:40 am by Dr Mark Summerfield
Abbott Medical Optics, Inc v Alcon Laboratories, Inc [2011] APO 79 (26 September 2011) Opposition – novelty – whether claimed method anticipated by prior published instructions and prior use where benefits of method previously unrecognised – whether ‘strict proof’ of prior use required This decision, issued by Delegate Dr B. [read post]